Article
Mainz, Germany-The accommodation capabilities of two IOLs (AT-45, CrystaLens, C&C Vision, Aliso Viejo, CA; and 1CU, HumanOptics AG, Erlangen, Germany) were clearly demonstrated in patients for the first time and compared with a standard IOL, which showed no accommodative effect, according to H. Burkhard Dick, MD.
Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies
Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery